A new role for public health in bioterrorism deterrence.
作者信息
Kosal Margaret E
机构信息
Georgia Institute of Technology, Sam Nunn School of International Affairs , Atlanta, GA , USA.
出版信息
Front Public Health. 2014 Dec 10;2:278. doi: 10.3389/fpubh.2014.00278. eCollection 2014.
Abstract
摘要
相似文献
1
A new role for public health in bioterrorism deterrence.公共卫生在生物恐怖主义威慑方面的新作用。
Front Public Health. 2014 Dec 10;2:278. doi: 10.3389/fpubh.2014.00278. eCollection 2014.
2
How COVID-19 is reshaping U.S. national security policy.新冠疫情如何重塑美国国家安全政策。
Politics Life Sci. 2024;43(1):83-98. doi: 10.1017/pls.2023.13. Epub 2023 Sep 27.
3
Managing biosecurity threats in China.应对中国的生物安全威胁。
Biosecur Bioterror. 2011 Mar;9(1):31-40. doi: 10.1089/bsp.2010.0060. Epub 2011 Mar 1.
4
[The strategic plan for preparedness and response to bioterrorism in Korea].[韩国生物恐怖主义防范与应对战略计划]
J Prev Med Public Health. 2008 Jul;41(4):209-13. doi: 10.3961/jpmph.2008.41.4.209.
5
Age of Bioterrorism: Are You Prepared? Review of Bioweapons and Their Clinical Presentation for Otolaryngologists.生物恐怖主义时代：你准备好了吗？耳鼻咽喉科医生对生物武器及其临床表现的综述。
Otolaryngol Head Neck Surg. 2014 Aug;151(2):208-14. doi: 10.1177/0194599814531907. Epub 2014 Apr 22.
6
From biodefence to biosecurity: the Obama administration's strategy for countering biological threats.从生物防御到生物安保：奥巴马政府应对生物威胁的战略。
Int Aff. 2012;88(1):131-48. doi: 10.1111/j.1468-2346.2012.01061.x.
7
Accelerating Action in Global Health Security: Global Biosecurity Dialogue as a Model for Advancing the Global Health Security Agenda.加速全球卫生安全行动：全球生物安保对话作为推进全球卫生安全议程的典范。
Health Secur. 2019 Nov/Dec;17(6):495-503. doi: 10.1089/hs.2019.0121.
8
BIOSECURITY. Assessing the bioweapons threat.生物安全。评估生物武器威胁。
Science. 2015 Aug 21;349(6250):792-3. doi: 10.1126/science.aab0713.
9
The National Response Plan: a new framework for homeland security, public health, and bioterrorism response.
J Health Law. 2005 Spring;38(2):287-318.
10
Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. A decade in biosecurity. Introduction.《生物安全与生物恐怖主义：生物防御战略、实践与科学》。生物安全的十年。引言。
Biosecur Bioterror. 2012 Mar;10(1):5. doi: 10.1089/bsp.2012.0319.
引用本文的文献
1
Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.设计和开发针对埃博拉病毒的疫苗、药物和疗法的进展。
Front Immunol. 2018 Aug 10;9:1803. doi: 10.3389/fimmu.2018.01803. eCollection 2018.
2
A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola Virus.关于植物源疫苗在抗击埃博拉病毒方面发展的展望
Front Immunol. 2017 Mar 10;8:252. doi: 10.3389/fimmu.2017.00252. eCollection 2017.
3
Biosecurity and dual-use research: gaining function - but at what cost?生物安全与两用研究：获得功能——但代价是什么？
Front Public Health. 2015 Feb 2;3:13. doi: 10.3389/fpubh.2015.00013. eCollection 2015.
本文引用的文献
1
The Ebola outbreak, fragile health systems, and quality as a cure.埃博拉疫情、脆弱的卫生系统以及作为一种疗法的质量。
JAMA. 2014 Nov 12;312(18):1859-60. doi: 10.1001/jama.2014.14387.
2
Early transmission dynamics of Ebola virus disease (EVD), West Africa, March to August 2014.2014年3月至8月西非埃博拉病毒病（EVD）的早期传播动态
Euro Surveill. 2014 Sep 11;19(36):20894. doi: 10.2807/1560-7917.es2014.19.36.20894.
3
Polio virus spreads from Syria to Iraq.脊髓灰质炎病毒从叙利亚传播至伊拉克。
BMJ. 2014 Apr 2;348:g2481. doi: 10.1136/bmj.g2481.
4
The eradication of polio--progress and challenges.消灭脊髓灰质炎——进展与挑战
N Engl J Med. 2006 Dec 14;355(24):2508-11. doi: 10.1056/NEJMp068200.
5
Risk of person-to-person transmission of pneumonic plague.肺鼠疫人传人的风险。
Clin Infect Dis. 2005 Apr 15;40(8):1166-72. doi: 10.1086/428617. Epub 2005 Mar 16.
6
Epidemiologic determinants for modeling pneumonic plague outbreaks.用于模拟肺鼠疫暴发的流行病学决定因素。
Emerg Infect Dis. 2004 Apr;10(4):608-14. doi: 10.3201/eid1004.030509.
7
The basic reproductive number of Ebola and the effects of public health measures: the cases of Congo and Uganda.埃博拉的基本繁殖数及公共卫生措施的影响：刚果和乌干达的案例
J Theor Biol. 2004 Jul 7;229(1):119-26. doi: 10.1016/j.jtbi.2004.03.006.
8
Polio eradication, cessation of vaccination and re-emergence of disease.脊髓灰质炎根除、疫苗接种停止与疾病再现。
Nat Rev Microbiol. 2004 Jun;2(6):473-82. doi: 10.1038/nrmicro906.
9
Getting polio eradication back on track in Nigeria.
N Engl J Med. 2004 Feb 12;350(7):645-6. doi: 10.1056/NEJMp038210.
10
A model for a smallpox-vaccination policy.一种天花疫苗接种政策模型。
N Engl J Med. 2003 Jan 30;348(5):416-25. doi: 10.1056/NEJMsa025075. Epub 2002 Dec 19.
Zotero 插件